Access to Investigational Medicines

Neumora engages in clinical research with the goal of obtaining regulatory approval of its medications to serve patients.

Clinical Trials: Clinical trials allow Neumora to evaluate our investigational medications in volunteers with the goal of generating the safety and efficacy information needed to obtain approval of these medications and make them available to the broader patient population. More information about Neumora’s investigational clinical trials can be found at  clinicaltrials.gov.

Expanded Access: Neumora’s investigational medications are generally intended for chronic use, and Neumora believes that access should be limited to clinical trial participants until such time as their safety, tolerability, and effectiveness have been determined in clinical trials and confirmed by regulatory authorities. As a result, we are not able to accept requests for expanded access to our investigational products.